Spots Global Cancer Trial Database for concurrent chemoradiation
Every month we try and update this database with for concurrent chemoradiation cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Magnetic Resonance Spectroscopic Imaging (MRS) and Tumor Perfusion of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide | NCT00250211 | Glioblastoma Glioma | Functional MRI ... | 18 Years - 65 Years | AHS Cancer Control Alberta | |
| Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma (NPC) | NCT00817583 | Nasopharyngeal ... | docetaxel, cisp... 3D-CRT (three-d... | 18 Years - 70 Years | Fudan University | |
| Comparison of Different Subsequent Treatments After Radical Surgery | NCT00806117 | Cervical Cancer | Radiotherapy (R... Concurrent chem... Sequence chemot... | 18 Years - 65 Years | Sun Yat-sen University | |
| Chemoradiotherapy for Limited Advanced Unresectable Thymic Epithelial Tumors | NCT02636556 | Thymoma and Thy... | concurrent chem... | 18 Years - 75 Years | Fudan University | |
| Efficacy Study for Postoperative Chemoradiation Using Triweekly Cisplatin in Cervical Cancer Patients | NCT00950261 | Cervical Neopla... | tri-weekly cisp... | - | Korea Cancer Center Hospital | |
| Phase I Study of Image-Guided Radiation Concurrent With Double-Agent Chemotherapy for Hepatocellular Carcinoma | NCT02403544 | Carcinoma, Hepa... | IGRT Capecitabine Oxaliplatin | 18 Years - 65 Years | ChineseAMS | |
| Concurrent Paclitaxel and Radiotherapy After Adjuvant Doxorubicin and Cyclophosphamide for Stage 2 or 3 Breast Cancer | NCT04809844 | Breast Cancer | Concurrent chem... | 18 Years - | Assiut University | |
| Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage Ⅲ Nasopharyngeal Carcinoma | NCT00816855 | Nasopharyngeal ... | docetaxel, cisp... | 18 Years - 70 Years | Fudan University | |
| A Study of Carilizumab Combined With Concurrent Chemoradiotherapy | NCT05151549 | Cervical Cancer | Camrelizumab Cisplatin or Ca... | 18 Years - | Hunan Cancer Hospital | |
| Postoperative IMRT Combined With Capecitabine for Advanced Gastric Cancer Patients | NCT01674959 | Gastric Cancer | concurrent chem... | 18 Years - 75 Years | ChineseAMS | |
| Efficacy Study for Postoperative Chemoradiation Using Triweekly Cisplatin in Cervical Cancer Patients | NCT00950261 | Cervical Neopla... | tri-weekly cisp... | - | Korea Cancer Center Hospital | |
| Concurrent Paclitaxel and Radiotherapy After Adjuvant Doxorubicin and Cyclophosphamide for Stage 2 or 3 Breast Cancer | NCT04809844 | Breast Cancer | Concurrent chem... | 18 Years - | Assiut University | |
| Postoperative IMRT Combined With Capecitabine for Advanced Gastric Cancer Patients | NCT01674959 | Gastric Cancer | concurrent chem... | 18 Years - 75 Years | ChineseAMS | |
| Combination of Chemotherapy Plus RT and SHR-1210 to Treat Patients With ESCC | NCT03671265 | Esophageal Canc... | SHR-1210 IMRT or VMAT Apatinib | 18 Years - 75 Years | Tianjin Medical University Cancer Institute and Hospital | |
| A Trial On 4 Cycles Of Neoadjuvant Chemotherapy Plus Concurrent Chemoradiation In N2-3 Nasopharyngeal Carcinoma | NCT02512315 | Nasopharyngeal ... | Docetaxel (DOC) Cisplatin (DDP) Concurrent chem... | - 70 Years | Sun Yat-sen University | |
| Neoadjuvant Chemotherapy Followed by Surgery Versus Concurrent Chemoradiation in Carcinoma of the Cervix | NCT00193739 | Cancer of Cervi... | NACT Radical abdomin... Inj.Cisplatin Concurrent chem... | 18 Years - 65 Years | Tata Memorial Hospital | |
| Consolidation Sintilimab After Concurrent Chemoradiation in Patients With Unresectable Stage III NSCLC | NCT03884192 | Carcinoma, Non-... | Consolidation S... | 18 Years - 75 Years | Shandong Cancer Hospital and Institute | |
| Doxorubicin Plus External-Beam Radiation Therapy in Treating Patients With Soft Tissue Sarcoma | NCT00004109 | Sarcoma | Doxorubicin Hyd... Radiation Thera... | 16 Years - | M.D. Anderson Cancer Center | |
| A Phase II Study of CRT Combined With QL1706 in ESCC Patients | NCT05490719 | Esophageal Squa... | QL1706 | 18 Years - 75 Years | Tianjin Medical University Cancer Institute and Hospital | |
| Comparison of Different Subsequent Treatments After Radical Surgery | NCT00806117 | Cervical Cancer | Radiotherapy (R... Concurrent chem... Sequence chemot... | 18 Years - 65 Years | Sun Yat-sen University | |
| Benefits of Immunonutrition in Patients With Head and Neck Cancer Receiving Chemoradiation | NCT05101889 | Oral Mucositis | Oral Impact® | 18 Years - 65 Years | Prince of Songkla University | |
| Study of Anlotinib With Chemoradiation for Patients With Locally Advanced Nasopharyngeal Carcinoma | NCT05232552 | Nasopharyngeal ... | Anlotinib hydro... induction chemo... concurrent chem... | 18 Years - 75 Years | Zhejiang Cancer Hospital | |
| Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage ⅣAB Nasopharyngeal Carcinoma | NCT00816816 | Nasopharyngeal ... | docetaxel, cisp... | 18 Years - 70 Years | Fudan University | |
| Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage ⅣAB Nasopharyngeal Carcinoma | NCT00816816 | Nasopharyngeal ... | docetaxel, cisp... | 18 Years - 70 Years | Fudan University | |
| Chemoradiation and Endothelial Progenitor Cells in Colorectal Cancer | NCT00325871 | Colorectal Canc... | concurrent chem... | 30 Years - 60 Years | Mackay Memorial Hospital | |
| Neoadjuvant Chemotherapy Followed by Surgery Versus Concurrent Chemoradiation in Carcinoma of the Cervix | NCT00193739 | Cancer of Cervi... | NACT Radical abdomin... Inj.Cisplatin Concurrent chem... | 18 Years - 65 Years | Tata Memorial Hospital | |
| Neoadjuvant Chemotherapy Followed by Surgery Versus Concurrent Chemoradiation in Carcinoma of the Cervix | NCT00193739 | Cancer of Cervi... | NACT Radical abdomin... Inj.Cisplatin Concurrent chem... | 18 Years - 65 Years | Tata Memorial Hospital | |
| A Study of Carilizumab Combined With Concurrent Chemoradiotherapy | NCT05151549 | Cervical Cancer | Camrelizumab Cisplatin or Ca... | 18 Years - | Hunan Cancer Hospital | |
| Magnetic Resonance Spectroscopic Imaging (MRS) and Tumor Perfusion of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide | NCT00250211 | Glioblastoma Glioma | Functional MRI ... | 18 Years - 65 Years | AHS Cancer Control Alberta | |
| Chemoradiation and Endothelial Progenitor Cells in Colorectal Cancer | NCT00325871 | Colorectal Canc... | concurrent chem... | 30 Years - 60 Years | Mackay Memorial Hospital | |
| Consolidation Sintilimab After Concurrent Chemoradiation in Patients With Unresectable Stage III NSCLC | NCT03884192 | Carcinoma, Non-... | Consolidation S... | 18 Years - 75 Years | Shandong Cancer Hospital and Institute | |
| Phase I Study of Image-Guided Radiation Concurrent With Double-Agent Chemotherapy for Hepatocellular Carcinoma | NCT02403544 | Carcinoma, Hepa... | IGRT Capecitabine Oxaliplatin | 18 Years - 65 Years | ChineseAMS | |
| Benefits of Immunonutrition in Patients With Head and Neck Cancer Receiving Chemoradiation | NCT05101889 | Oral Mucositis | Oral Impact® | 18 Years - 65 Years | Prince of Songkla University | |
| Neoadjuvant CCRT With/Without Bevacizumab for Locally Advanced ESCC | NCT02812641 | Stage III Esoph... | BPF-CCRT (run-i... BPF-CCRT (rando... PF-CCRT (random... | 20 Years - | National Taiwan University Hospital | |
| A Study of Camrelizumab Combined With Concurrent Chemoradiation in Patients With Cervical Cancer | NCT04974827 | Cervical Cancer | Camrelizumab Cisplatin or Ca... | 18 Years - | Hunan Cancer Hospital | |
| Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage Ⅲ Nasopharyngeal Carcinoma | NCT00816855 | Nasopharyngeal ... | docetaxel, cisp... | 18 Years - 70 Years | Fudan University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
